ask="1.25"
ask_size="800"
average_daily_volume="284822"
bid="0.70"
bid_size="100"
book_value="0.51"
change="+0.00"
change_from_200_day_moving_average="-0.06"
change_from_50_day_moving_average="-0.23"
change_from_52_week_high="-1.68"
change_From_52_week_low="0.31"
change_in_percent="+0.00%"
close="1.21"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.29"
ebitda="0.00"
eps_estimate_current_year="-0.98"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-1.03"
ex_dividend_date="N/A"
float_shares="12508000"
high="1.32"
high_52_weeks="2.89"
last_trade_date="3/16/2017"
last_trade_price="1.21"
last_trade_size="145"
last_trade_time="4:00pm"
low="1.18"
low_52_weeks="0.90"
market_capitalization="24.41M"
moving_average_200_day="1.27"
moving_average_50_day="1.44"
name="Viking Therapeutics
Inc."
notes="N/A"
one_year_target_price="7.00"
open="1.21"
pe_ratio="N/A"
peg_ratio="-0.03"
percent_change_from_200_day_moving_average="-4.83%"
percent_change_from_50_day_moving_average="-16.19%"
percent_change_from_52_week_high="-58.13%"
percent_change_from_52_week_low="+34.30%"
previous_close="1.21"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.35"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="20170000"
short_ratio="1.76"
stock_exchange="NCM"
symbol="VKTX"
volume="189692"
weeks_range_52="0.90 - 2.89"
